Posts

WBIR 10 News Features TEAM Technologies’ Rapid Antigen COVID-19 Tests

/in , , /by

Knoxville NBC news station WBIR interviews TEAM Technologies’ CEO, Marshall White, on the company’s involvement in the fight against COVID-19. Watch the interview and read the entire article here.

TEAM Technologies is working with Maryland-based Maxim Biomedical to develop the point-of-care rapid antigen tests for COVID-19 that produce results in 15 minutes. Leveraging its expertise in a variety of services and capabilities ranging from product development, supply line expertise, to packaging and kitting, TEAM Technologies is planning to help produce 3 million kits by the end of the year and increase to 3 million per month and beyond as long as tests are needed.

As part of an effort to boost COVID-19 testing capacity, this project has been funded in part by the NIH Rapid Acceleration of Diagnostics (RADx SM) initiative with federal funds from the National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, Department of Health and Human Services.

Read the press release here.

 

TEAM Technologies to Produce Rapid Antigen COVID-19 Tests

/in , /by

TEAM Technologies Leverages Medical Device Capabilities in Partnership with Maxim Biomedical to Produce Rapid Antigen COVID-19 (SARS-CoV-2) Tests that Deliver Results in 15 Minutes

Developed in conjunction with Maxim Biomedical Inc. and the National Institutes of Health (NIH), the Rapid Antigen Diagnostic Tests offer Fast and Easy-to-Read Results Ideal for Point-of-Care (POC) Use

Morristown, TN — September 8, 2020 — As part of its growing portfolio of medical device and healthcare solutions, TEAM Technologies will produce point-of-care (POC) tests to assist organizations seeking the benefits of rapid testing for COVID-19. TEAM Technologies is producing the in-vitro diagnostic (IVD) test with Maxim Biomedical, who developed the test as part of the NIH Rapid Acceleration of Diagnostics RADxSM initiative, a program launched last April to speed innovation in the development, commercialization, and implementation of testing technologies for COVID-19.

TEAM Technologies has facilities across the United States providing a variety of services ranging from product development, supply line expertise, and packaging and kitting of the SARS-CoV-2 diagnostic tests. “We are pleased to be working with the team at Maxim Biomedical as an instrumental partner in bringing this much needed testing solution to market,” commented Marshall White, President and CEO of TEAM Technologies. Collectively, TEAM and Maxim currently have a goal to produce 3 million tests by year’s end and to achieve a production rate of 15 million tests per month in early 2021.

The SARS-CoV-2 Rapid Antigen Diagnostic Test utilizes Lateral Flow Assay (LFA) technology with a streamlined workflow and a closed-tube format that eliminates the need for expensive equipment or a reader to perform. The assay achieves this by combining the specimen swab, reagents, and test strip in a compact, self-contained environment, allowing for incubation, reading and disposal in one tube. Results are available within 15 minutes and stable for more than two hours.

Complementing the IVD and POC experience of Maxim Biomedical, TEAM Technologies is employing its medical device manufacturing capabilities to rapidly scale production quantities of the SARS-CoV-2 rapid antigen test. “Many organizations, from schools to businesses to factories, can benefit from having the ability to perform testing that produces safe, quick and easy-to-interpret results,” White added. “We are proud to partner with our colleagues at Maxim Biomedical to make this test available.”

Mr. Jonathan Maa, COO of Maxim Biomedical, Inc. said, “Maxim Biomedical has always endeavored to provide high quality testing where it would fulfil unmet needs.  The urgent demand for testing is an opportunity to apply our expertise in LFA technology.  We developed a point-of-care rapid antigen test that is safe for community use and reduces risk for patients and front-line workers.  We are glad we found a partner like TEAM Technologies to help us bring this important test to market.”

As part of an effort to boost COVID-19 testing capacity, this project has been funded in part by the NIH Rapid Acceleration of Diagnostics (RADx SM) initiative with federal funds from the National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, Department of Health and Human Services, under Contract No. 75N92020C00020.

This SARS-CoV-2 Rapid Antigen Diagnostic Test has not been FDA cleared or approved.

About TEAM Technologies
Headquartered in Morristown, TN with 13 facilities throughout the United States, TEAM Technologies is a leading solutions provider supporting the foremost global healthcare products companies. With its ‘ONE TEAM, MANY TECHNOLOGIES’ philosophy, TEAM boasts an extensive lineup of manufacturing processes designed to service the oral care, infection prevention and control, advanced wound care, pharmaceutical dispensing, IVD diagnostics and other medical end markets. With an entrepreneurial mindset and a management team with deep industry experience, TEAM Technologies leverages seamless, turnkey processes and innovation to positively impact the success of TEAM’s customers.  For more information, visit teamtech.com.

About Maxim Biomedical Inc.
Founded in 2005 as a branch of the Maxim family of businesses, Maxim Biomedical (www.maximbio.com) was created as a company dedicated to the development of high quality, in-vitro diagnostic (IVD) and Point-of-Care (POC) testing solutions that make positive contributions to public health and healthcare worldwide. The company, located in Rockville, Maryland places Maxim Biomedical in one of the world’s top scientific regions, just steps away from our nation’s capital. Maxim Biomedical’s 26,000 square foot facility houses over 13 individual laboratories.  The company offers a line of FDA and CDC approved products, as well as raw materials, and customized CRO/CMO services.

Forward Looking Statements
This press release contains forward-looking statements within the meaning of the federal securities laws that involve material risks, assumptions and uncertainties. Many possible events or factors could affect our future financial results and performance, such that our actual results and performance may differ materially from those that may be described or implied in the forward-looking statements. As such, no forward-looking statement can be guaranteed. Differences in actual results and performance may arise as a result of a number of factors including, without limitation: the impact of the novel virus (COVID-19) global pandemic; an inability to agree on a definitive agreement or meet key deliverables and milestones under the NIH’s RADx-ATP contract.

TEAM Technologies Strengthens its Medical Manufacturing Solutions with the addition of Baril Corporation

/in , , /by

MORRISTOWN, TN, August 25, 2020 – TEAM Technologies has expanded its capabilities to support the design and manufacture of medical device technology and healthcare products with the addition of Baril Corporation. This further extends TEAM Technologies’ ability to provide a growing portfolio of products and services to meet the needs of customers in the medical device, healthcare, dental, and oral care markets while increasing its geographical manufacturing footprint within the United States.

Located in Haverhill, MA, Baril Corporation has contributed nearly 50 years of expert contract manufacturing services to medical product companies around the world and serves a wide range of markets including wound care, patient monitoring, clinical chemistry and single-use surgical and medical devices. Baril’s experience in rapid prototyping capabilities, engineering and inventory storage capacity has allowed them to bring customers’ concepts and ideas to market faster than their competition.

“As a leading U.S. manufacturer, TEAM Technologies is pleased to welcome everyone at Baril Corporation to our TEAM,” said Marshall White, President and CEO of TEAM Technologies. “Having a strong partner like Baril enhances our ability to serve our collective customers in the medical device market and support their product development needs. Being ONE TEAM with MANY TECHNOLOGIES means we can provide solutions that revolutionize the healthcare markets we serve and improve the lives of countless patients.”

“Baril Corporation continues its focus on innovative customer solutions,” said Dan Baril, CEO and owner of Baril Corporation. “For decades, we have been successfully driving growth in the healthcare industry with process expertise in flexible materials and adhesives. Now, by combining with TEAM, we offer our customers the benefit of even greater possibilities through expanded product capabilities and solutions.”

The addition of Baril Corporation enhances TEAM Technologies’ strategy of expanding its medical device capabilities and resources to meet customer needs. Offering the benefits of a variety of services ranging from product design and development to finished device manufacturing, assembly and packaging, TEAM Technologies is suited to meet the needs of companies and industries seeking innovative and efficient commercialization and product development solutions. With facilities located within the United States, the company is well positioned to provide the benefits of working with North American resources which can improve quality control and reduce product lead times.

About TEAM Technologies
Headquartered in Morristown, TN, with 13 facilities throughout the United States, TEAM Technologies is a leading specialty manufacturer providing solutions to support companies in the global healthcare products industry. Its ‘ONE TEAM, MANY TECHNOLOGIES’ philosophy uniquely positions TEAM Technologies to be your ONE PARTNER with many solutions and capabilities including innovative product development, expert design and efficient manufacturing processes to support both medical and dental end markets. TEAM also boasts an extensive lineup of products designed to service these end markets which include medical supplies, pharmaceutical packaging and supplies, infection prevention, veterinary health, oral healthcare and consumer health. With an entrepreneurial mindset and a management team with deep industry experience, TEAM Technologies has experienced tremendous growth over the last 30 years by leveraging seamless, turnkey processes and innovation to positively impact the success of TEAM’s customers. For more information, visit www.teamtech.com.

About Baril Corporation

Headquartered in Haverhill, MA, Baril Corporation is the premier end-to-end contract manufacturer of disposable single-use medical products in infection protection, wound care, clinical chemistry, patient monitoring, and medical and surgical disposables. In addition to being QSR-GMP compliant, Baril Corporation is ISO 13485, ISO 9001, and ISO 14644 Class 7 Clean Room certified, Baril is MDSAP-certified (Medical Device Single Audit Program). and holds itself to a higher quality standard. With a U.S.-based supply chain, rapid prototyping capabilities, deep engineering expertise, and available capacity, Baril can pivot quickly to meet market demand. For more information, visit www.barilcorp.com.